DoHAC targets four areas in new compliance activity Around 100 GPs will receive letters for high MBS activity in areas including timed professional services and chronic disease management.
Antipsychotics spiking cardiac risks: Study Researchers have revealed 10% of patients on quetiapine and haloperidol develop heart rhythm disorders, leading to calls for increased monitoring.
Does montelukast need a warning label? The asthma medication is known to cause behavioural and neuropsychiatric disturbance that in rare cases have been linked to suicidal ideation.
Concerns flagged for ‘alarming’ teen weight loss trend Research prompts calls for GPs to help regulate use of non-prescribed weight-loss products among teens displaying ‘risk-taking behaviour’.
Perinatal depression leads to increased risk of death: Study A review of one million people has linked perinatal depression to an increased risk of taking one’s own life, even decades after giving birth.
‘Extremely agitated’ patient pulls gun on GP The RACGP is urging members to seek out support after police shot and killed a man who had held a GP hostage for parts of a ‘terrifying’ two-hour stand-off.
Support for RACGP warning on immediate pathology results Pathologists say removing the seven-day delay on uploading reports to My Health Record may lead to misinformation and patient distress.
In Practice: 1 January MBS changes The new year will bring changes to Medicare Safety Net and smoking cessation MBS items.
Syphilis rates triple in 10 years amid STI spike Experts say it is ‘concerning’ to see infections on the rise despite a decrease in testing, and are urging patients to seek out their GP.
One in two Australians living with a chronic condition Mental and behavioural conditions were the most prevalent in 2022, followed by back problems and arthritis.